A recent FiercePharma article discussed the newest business venture for billionaire serial entrepreneur and investor. Cuban is probably best known as the owner of the Dallas Mavericks and tv personality on Shark Tank where he and a panel of other investors listen to startups pitches and decide whether or not to invest. Cuban’s new company is called Mark Cuban Cost Plus Drugs, and it touts itself as providing “radically transparent, low cost versions of high cost generic drugs.”
Consistent with the message of transparency, Cuban says the company will disclose the cost of development and distribution for each of its products and then add a 15% margin to arrive at a wholesale price. The company’s first product will be albendazole, an antiparasitic with an average cash price of $225 per tablet, that Cost Plus will sell at $20 per tablet. Cuban is building a manufacturing facility in Dallas, and plans to be marketing more than 100 drugs by the end of 2021.
.jpg?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=146&w=340)
